Skip to content

Clinical trials

Phase 3 Renal Insufficiency, Chronic trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Renal Insufficiency, Chronic Phase: Phase 3 Country / region: Belgium Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20081
20093
20101
20111
20136
20143
20152
20163
20171
20182
20193
20213
20223
20231
20245
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Active, not recruiting9
Terminated6
Recruiting5
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen11
AstraZeneca3
Bayer3
Astellas Pharma Europe B.V.2
Boehringer Ingelheim2
Eli Lilly and Company2
GlaxoSmithKline2
Novartis Pharmaceuticals2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
Alexion Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Renal Insufficiency, Chronic44
Hyperparathyroidism, Secondary8
Anemia7
Kidney Diseases7
Kidney Failure, Chronic5
Glomerulonephritis, IGA4
Proteinuria4
Diabetes Mellitus, Type 23
Heart Failure3
Hypertension3

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.